FBQI5103-2 Analisis de Medicamentos Doping y Drogas de Abuso

USP Chromatography 621.PDF 21 Mar 201621/03/16 at 10:052016-03-21 10:05:21

Guillermo A. Diaz Araya
TLC identification test 201.PDF 21 Mar 201621/03/16 at 10:052016-03-21 10:05:21

Guillermo A. Diaz Araya
Sulfaguanidina comprimidos FI.PDF 21 Mar 201621/03/16 at 10:042016-03-21 10:04:21

Guillermo A. Diaz Araya
Nicotinamida BP 2003.PDF 21 Mar 201621/03/16 at 10:042016-03-21 10:04:21

Guillermo A. Diaz Araya
Lidocaina Sterile Solution BP2003.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya
Fenobarbital Int Pharmacop 4th Ed.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya
CHROMATOGRAPHIC REAGENTS.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya
cafeina USP 29 2016.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya
Benzethonium Chloride Topical Solution USP30.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya
Aspirin USP30.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya
Acetaminofeno solución oral USP29.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya
Acetaminofeno capsulas USP29.PDF 21 Mar 201621/03/16 at 08:432016-03-21 08:43:21

Guillermo A. Diaz Araya
TP N° 2 Análisis Solicitados.PDF 21 Mar 201621/03/16 at 08:392016-03-21 08:39:21

Guillermo A. Diaz Araya
TP N° 1 Análisis solicitados.PDF 21 Mar 201621/03/16 at 08:382016-03-21 08:38:21

Guillermo A. Diaz Araya
Copia de Grupos T P Análisis de medicamentos.pdf 21 Mar 201621/03/16 at 08:382016-03-21 08:38:21

Guillermo A. Diaz Araya
Re (2): pareja tp 10 Mar 201610/03/16 at 08:592016-03-10 08:59:10

Marco Mora F.
Re (1): pareja tp 10 Mar 201610/03/16 at 07:152016-03-10 07:15:10

Katherine Ramírez Uribe
pareja tp 10 Mar 201610/03/16 at 01:102016-03-10 01:10:10

Marco Mora F.
Programa_Curso_AMMDA_2016.docx 8 Mar 201608/03/16 at 17:452016-03-08 17:45:08

Guillermo A. Diaz Araya

U-Cursos ::

FBQI5103-2 Analisis de Medicamentos Doping y Drogas de Abuso 2016, Primer Semestre

Analisis de Medicamentos Doping y Drogas de Abuso

FBQI5103-2 - Primer Semestre 2016

Historial

USP Chromatography 621.PDF 21 Mar 201621/03/16 at 10:052016-03-21 10:05:21

Guillermo A. Diaz Araya

TLC identification test 201.PDF 21 Mar 201621/03/16 at 10:052016-03-21 10:05:21

Guillermo A. Diaz Araya

Sulfaguanidina comprimidos FI.PDF 21 Mar 201621/03/16 at 10:042016-03-21 10:04:21

Guillermo A. Diaz Araya

Nicotinamida BP 2003.PDF 21 Mar 201621/03/16 at 10:042016-03-21 10:04:21

Guillermo A. Diaz Araya

Lidocaina Sterile Solution BP2003.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya

Fenobarbital Int Pharmacop 4th Ed.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya

CHROMATOGRAPHIC REAGENTS.PDF 21 Mar 201621/03/16 at 10:032016-03-21 10:03:21

Guillermo A. Diaz Araya

cafeina USP 29 2016.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya

Benzethonium Chloride Topical Solution USP30.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya

Aspirin USP30.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya

Acetaminofeno solución oral USP29.PDF 21 Mar 201621/03/16 at 10:022016-03-21 10:02:21

Guillermo A. Diaz Araya

Acetaminofeno capsulas USP29.PDF 21 Mar 201621/03/16 at 08:432016-03-21 08:43:21

Guillermo A. Diaz Araya

TP N° 2 Análisis Solicitados.PDF 21 Mar 201621/03/16 at 08:392016-03-21 08:39:21

Guillermo A. Diaz Araya

TP N° 1 Análisis solicitados.PDF 21 Mar 201621/03/16 at 08:382016-03-21 08:38:21

Guillermo A. Diaz Araya

Copia de Grupos T P Análisis de medicamentos.pdf 21 Mar 201621/03/16 at 08:382016-03-21 08:38:21

Guillermo A. Diaz Araya

Re (2): pareja tp 10 Mar 201610/03/16 at 08:592016-03-10 08:59:10

Marco Mora F.

Re (1): pareja tp 10 Mar 201610/03/16 at 07:152016-03-10 07:15:10

Katherine Ramírez Uribe

pareja tp 10 Mar 201610/03/16 at 01:102016-03-10 01:10:10

Marco Mora F.

Programa_Curso_AMMDA_2016.docx 8 Mar 201608/03/16 at 17:452016-03-08 17:45:08

Guillermo A. Diaz Araya